Actively Recruiting
Impact of TTNS on Bladder Symptoms Among People With MS, A RCT
Led by Hawra Al-Dandan · Updated on 2026-04-15
72
Participants Needed
1
Research Sites
110 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Background: Neurogenic lower urinary tract dysfunction is common among people with multiple sclerosis (MS). Recent studies showed that bladder storage symptoms are predominant among MS with a pooled prevalence of frequency at 73.45% followed by urgency at 63.87%. Transcutaneous tibial nerve stimulation (TTNS) is a non-invasive treatment to manage bladder storage symptoms; however, the effectiveness of TTNS is based on a small number of studies with the absence of high-quality evidence. This study aims to investigate the effectiveness of TTNS on bladder storage symptoms compared with sham TTNS among people with MS.Methods: The investigators will use a randomised sham controlled double blind study to explore the effectiveness of TTNS in the treatment of bladder storage symptoms in MS. the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) was followed to standardize the conduct and reporting of the current protocol. The recruitment plan is twofold: 1) Open recruitment for people with MS through King Fahd Hospital of the University communication channels; 2) people with any type of MS attending their routine appointments in MS clinic at King Fahd Hospital of the University, Al Khobar. The investigators will investigate the effectiveness of TTNS compared to sham TTNS on bladder storage symptoms and the effect on quality of life using ICIQ-OAB, ICIQ 3-day bladder diary, ICIQ-LUTS qol, and PSQI. Participant's perception of change post intervention will be evaluated using GPE. Outcomes will be measured at 0, 6 weeks and at 6 months post intervention. A sample size of 72 patients (36 in each group) is required to achieve 90% power with two-tailed tests at an alpha level of 0.05. Conclusion: Multiple sclerosis is a long-term condition, and self-management is important. TTNS provide a safe, non-invasive intervention that can be administered at home. Should the trial determine that TTNS is effective compared to sham TTNS, the investigators will plan to integrate TTNS into standard clinical care pathways in MS.
CONDITIONS
Official Title
Impact of TTNS on Bladder Symptoms Among People With MS, A RCT
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ambulatory (with or without assistive device)
- Aged 18 years or older
- Able to understand spoken and written Arabic language
- Self-reported at least one bladder storage symptom such as urinary frequency, urinary urgency, nocturia, with or without urge urinary incontinence
- Willing to give written informed consent
- Able to understand how to complete study outcome measures
You will not qualify if you...
- Presence of indwelling urethral catheter
- Presence of indwelling suprapubic catheter
- Bladder malignancy
- Diabetes mellitus
- Pregnant women or planning pregnancy during the study
- Pelvic-related surgery within the last year
- Pacemaker or other metallic internal devices
- Urinary tract infections during recruitment phase
- Unable to understand instructions for operating the device
- Received bladder BOTOX injection in the last 12 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
King Fahd Hospital of the University
Khobar, Eastern Providence, Saudi Arabia
Actively Recruiting
Research Team
D
Dr Hawra Al Dandan, PhD
CONTACT
D
Dr Saad Al Saadi, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here